The phosphorylated MARCKS Ser-159/163 levels were reduced by approximately 35% in MANS peptide-treated A2058 melanoma cells compared to cells treated with the RNS control peptide (Figure 4A,C). This evidence concerns the gene MARCKS and melanoma.